| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | FBLN5 LAMA5 PAPLN LAMC2 SSPOP CRELD1 FBLN2 FBN1 FBN2 PRG3 HMCN2 HMCN1 LTBP1 LTBP2 MUC5AC FBN3 | 2.20e-15 | 188 | 103 | 16 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | FBLN7 FBLN5 DNER CUBN LRP1B SVEP1 CRB1 JAG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 SYT13 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 6.09e-15 | 749 | 103 | 26 | GO:0005509 |
| GeneOntologyMolecularFunction | structural molecule activity | FBLN5 OBSCN OLFM4 LAMA5 PAPLN LAMC2 SSPOP CRELD1 FBLN2 FBN1 FBN2 PRG3 HMCN2 HMCN1 KRT71 LTBP1 LTBP2 MUC5AC FBN3 | 1.29e-07 | 891 | 103 | 19 | GO:0005198 |
| GeneOntologyMolecularFunction | Notch binding | 2.44e-07 | 27 | 103 | 5 | GO:0005112 | |
| GeneOntologyMolecularFunction | integrin binding | 3.07e-07 | 175 | 103 | 9 | GO:0005178 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 3.20e-07 | 12 | 103 | 4 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 6.42e-07 | 14 | 103 | 4 | GO:0097493 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FBLN5 ADAM18 ADAM15 ICAM3 OBSCN OLFM4 LAMA5 ITGA2 ITGB2 SVEP1 FBN1 CCS NOTCH3 | 1.26e-05 | 599 | 103 | 13 | GO:0050839 |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.77e-05 | 73 | 103 | 5 | GO:0050840 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 5.60e-05 | 257 | 103 | 8 | GO:0061134 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 6.43e-05 | 42 | 103 | 4 | GO:0042887 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 7.11e-05 | 16 | 103 | 3 | GO:0035673 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.70e-04 | 323 | 103 | 8 | GO:1901681 | |
| GeneOntologyMolecularFunction | microfibril binding | 3.90e-04 | 6 | 103 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 4.20e-04 | 187 | 103 | 6 | GO:0030414 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 4.42e-04 | 29 | 103 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | heparin binding | 4.83e-04 | 192 | 103 | 6 | GO:0008201 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 7.10e-04 | 34 | 103 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 9.26e-04 | 9 | 103 | 2 | GO:0098634 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 9.81e-04 | 85 | 103 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.21e-03 | 90 | 103 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 2.14e-03 | 105 | 103 | 4 | GO:0004867 | |
| GeneOntologyMolecularFunction | phosphatidate phosphatase activity | 2.30e-03 | 14 | 103 | 2 | GO:0008195 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 2.30e-03 | 14 | 103 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 2.32e-03 | 51 | 103 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 2.42e-03 | 180 | 103 | 5 | GO:0004866 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 2.65e-03 | 15 | 103 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.67e-03 | 268 | 103 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.02e-03 | 16 | 103 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 3.47e-03 | 120 | 103 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 3.82e-03 | 18 | 103 | 2 | GO:0015347 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 3.88e-03 | 201 | 103 | 5 | GO:0061135 | |
| GeneOntologyMolecularFunction | clathrin binding | 4.23e-03 | 63 | 103 | 3 | GO:0030276 | |
| GeneOntologyMolecularFunction | lipid phosphatase activity | 4.26e-03 | 19 | 103 | 2 | GO:0042577 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.39e-03 | 207 | 103 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.48e-03 | 208 | 103 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 4.71e-03 | 20 | 103 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.19e-03 | 21 | 103 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 5.68e-03 | 70 | 103 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 6.38e-03 | 73 | 103 | 3 | GO:0170055 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | FBLN5 ADAM15 OLFM4 LAMA5 ITGA2 ITGB2 SVEP1 SNED1 FBLN2 LPA LRP1 NOTCH1 EPHA1 | 1.05e-07 | 410 | 101 | 13 | GO:0031589 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | FBLN5 ADAMTSL1 ADAM15 PAPLN ITGA2 ADAMTSL3 HMCN1 LPA LRP1 ADAMTS18 ADAMTS20 NOTCH1 | 3.23e-07 | 377 | 101 | 12 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | FBLN5 ADAMTSL1 ADAM15 PAPLN ITGA2 ADAMTSL3 HMCN1 LPA LRP1 ADAMTS18 ADAMTS20 NOTCH1 | 3.32e-07 | 378 | 101 | 12 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | FBLN5 ADAMTSL1 ADAM15 PAPLN ITGA2 ADAMTSL3 HMCN1 LPA LRP1 ADAMTS18 ADAMTS20 NOTCH1 | 3.41e-07 | 379 | 101 | 12 | GO:0045229 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 4.54e-07 | 4 | 101 | 3 | GO:0035583 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 6.27e-06 | 8 | 101 | 3 | GO:0071694 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 1.83e-05 | 11 | 101 | 3 | GO:0035581 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 3.15e-05 | 13 | 101 | 3 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 3.15e-05 | 13 | 101 | 3 | GO:1900116 | |
| GeneOntologyBiologicalProcess | regeneration | 3.37e-05 | 252 | 101 | 8 | GO:0031099 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | ADAM15 CYTH1 OLFM4 LAMA5 ITGA2 ITGB2 CEACAM1 JAG2 FBLN2 LPA LRP1 ADAMTS18 NOTCH1 NOTCH4 EPHA1 | 4.41e-05 | 927 | 101 | 15 | GO:0030155 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 5.49e-05 | 270 | 101 | 8 | GO:0007160 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 7.10e-05 | 3 | 101 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | axon guidance | 8.02e-05 | 285 | 101 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 8.21e-05 | 286 | 101 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | positive regulation of aorta morphogenesis | 1.42e-04 | 4 | 101 | 2 | GO:1903849 | |
| GeneOntologyBiologicalProcess | astrocyte activation involved in immune response | 1.42e-04 | 4 | 101 | 2 | GO:0002265 | |
| GeneOntologyBiologicalProcess | oligopeptide transport | 1.88e-04 | 23 | 101 | 3 | GO:0006857 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 2.54e-04 | 254 | 101 | 7 | GO:0010810 | |
| GeneOntologyBiologicalProcess | vasculature development | FBLN5 ADAM15 GRN ITGB2 SVEP1 CEACAM1 LPA LRP1 LTBP1 NOTCH1 NOTCH2 NOTCH3 NOTCH4 EPHA1 | 2.64e-04 | 969 | 101 | 14 | GO:0001944 |
| GeneOntologyBiologicalProcess | cell activation | TNFRSF9 CTSC WWP1 GRN ITGB2 SVEP1 CEACAM1 JAG2 PRG3 SLC15A4 LRP1 ADAMTS18 CD79A CD79B IL17RA NOTCH2 IL9 | 2.98e-04 | 1356 | 101 | 17 | GO:0001775 |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 3.42e-04 | 28 | 101 | 3 | GO:0051152 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 3.52e-04 | 6 | 101 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 3.52e-04 | 6 | 101 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 3.52e-04 | 6 | 101 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | regulation of aorta morphogenesis | 3.52e-04 | 6 | 101 | 2 | GO:1903847 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 3.52e-04 | 6 | 101 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 3.62e-04 | 124 | 101 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | glial cell activation | 3.88e-04 | 70 | 101 | 4 | GO:0061900 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 4.09e-04 | 71 | 101 | 4 | GO:0002347 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 4.20e-04 | 30 | 101 | 3 | GO:0072012 | |
| GeneOntologyBiologicalProcess | tube development | FBLN5 TMEM94 ADAM15 WWP1 LAMA5 GRN ITGB2 CEACAM1 FBN1 LPA LRP1 CSMD1 NOTCH1 NOTCH2 NOTCH3 NOTCH4 EPHA1 | 4.39e-04 | 1402 | 101 | 17 | GO:0035295 |
| GeneOntologyBiologicalProcess | kidney vasculature development | 4.64e-04 | 31 | 101 | 3 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 4.64e-04 | 31 | 101 | 3 | GO:0061437 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 4.79e-04 | 74 | 101 | 4 | GO:0010812 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 4.91e-04 | 7 | 101 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 4.91e-04 | 7 | 101 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 4.91e-04 | 7 | 101 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | artery development | 4.99e-04 | 133 | 101 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 5.16e-04 | 134 | 101 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 5.89e-04 | 210 | 101 | 6 | GO:0007219 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 5.90e-04 | 138 | 101 | 5 | GO:0030512 | |
| GeneOntologyBiologicalProcess | blood vessel development | FBLN5 ADAM15 GRN ITGB2 CEACAM1 LPA LRP1 LTBP1 NOTCH1 NOTCH2 NOTCH3 NOTCH4 EPHA1 | 6.00e-04 | 929 | 101 | 13 | GO:0001568 |
| GeneOntologyBiologicalProcess | circulatory system development | FBLN5 TMEM94 ADAM15 GRN ITGB2 SVEP1 CEACAM1 CRELD1 FBN1 LPA LRP1 LTBP1 NOTCH1 NOTCH2 NOTCH3 NOTCH4 EPHA1 | 6.05e-04 | 1442 | 101 | 17 | GO:0072359 |
| GeneOntologyBiologicalProcess | aorta development | 6.44e-04 | 80 | 101 | 4 | GO:0035904 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | FBLN5 ADAM15 GRN ITGB2 CEACAM1 LPA LRP1 NOTCH1 NOTCH2 NOTCH3 NOTCH4 EPHA1 | 6.47e-04 | 817 | 101 | 12 | GO:0048514 |
| GeneOntologyBiologicalProcess | angiogenesis | FBLN5 ADAM15 GRN ITGB2 CEACAM1 LPA NOTCH1 NOTCH2 NOTCH3 NOTCH4 EPHA1 | 6.94e-04 | 708 | 101 | 11 | GO:0001525 |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 6.99e-04 | 217 | 101 | 6 | GO:1903034 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 7.16e-04 | 218 | 101 | 6 | GO:0090101 | |
| GeneOntologyBiologicalProcess | endocytosis | ICAM3 DNER GRN USP46 ITGA2 CUBN LRP1B ITGB2 CEACAM1 ATP6V1H LRP1 LRP3 | 7.19e-04 | 827 | 101 | 12 | GO:0006897 |
| GeneOntologyBiologicalProcess | superoxide metabolic process | 7.40e-04 | 83 | 101 | 4 | GO:0006801 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 8.36e-04 | 9 | 101 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | positive regulation of artery morphogenesis | 8.36e-04 | 9 | 101 | 2 | GO:1905653 | |
| GeneOntologyBiologicalProcess | regulation of axon regeneration | 9.87e-04 | 40 | 101 | 3 | GO:0048679 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 9.87e-04 | 40 | 101 | 3 | GO:0097242 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion mediated by cadherin | 1.04e-03 | 10 | 101 | 2 | GO:2000048 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 1.06e-03 | 41 | 101 | 3 | GO:0035909 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.09e-03 | 92 | 101 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | FBLN5 ADAM15 LAMA5 GRN ITGB2 CEACAM1 LPA LRP1 CSMD1 NOTCH1 NOTCH2 NOTCH3 NOTCH4 EPHA1 | 1.15e-03 | 1125 | 101 | 14 | GO:0035239 |
| GeneOntologyBiologicalProcess | axon development | 1.20e-03 | 642 | 101 | 10 | GO:0061564 | |
| GeneOntologyBiologicalProcess | glomerulus morphogenesis | 1.27e-03 | 11 | 101 | 2 | GO:0072102 | |
| GeneOntologyBiologicalProcess | negative regulation of myelination | 1.27e-03 | 11 | 101 | 2 | GO:0031642 | |
| GeneOntologyCellularComponent | extracellular matrix | FBLN7 FBLN5 ADAMTSL1 ZAN CTSC LAMA5 PAPLN LAMC2 ADAMTSL3 SSPOP SVEP1 LRIG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 FCGBP PRG3 HMCN2 HMCN1 LPA ADAMTS18 ADAMTS20 LTBP1 LTBP2 USH2A MUC5AC FBN3 | 4.02e-21 | 656 | 103 | 30 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | FBLN7 FBLN5 ADAMTSL1 ZAN CTSC LAMA5 PAPLN LAMC2 ADAMTSL3 SSPOP SVEP1 LRIG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 FCGBP PRG3 HMCN2 HMCN1 LPA ADAMTS18 ADAMTS20 LTBP1 LTBP2 USH2A MUC5AC FBN3 | 4.39e-21 | 658 | 103 | 30 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | FBLN5 ADAMTSL1 CTSC LAMA5 PAPLN LAMC2 SSPOP CRELD1 EYS FBLN2 FBN1 FBN2 PRG3 HMCN2 HMCN1 LPA ADAMTS20 LTBP1 LTBP2 USH2A | 1.24e-12 | 530 | 103 | 20 | GO:0062023 |
| GeneOntologyCellularComponent | microfibril | 3.84e-07 | 13 | 103 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | external side of plasma membrane | FCRL2 TNFRSF9 ITGA2 TNFRSF10C CUBN ITGB2 CEACAM1 LPA LRP1 CD79A CD79B ABCG2 ADGRA3 | 1.64e-06 | 519 | 103 | 13 | GO:0009897 |
| GeneOntologyCellularComponent | cell surface | FCRL2 TNFRSF9 ADAM15 ITGA2 TNFRSF10C CUBN ITGB2 CEACAM1 SCUBE2 LPA LRP1 CD79A CD79B ABCG2 NOTCH1 NOTCH2 ADGRA3 NOTCH3 NOTCH4 | 1.82e-06 | 1111 | 103 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | basement membrane | 2.42e-06 | 122 | 103 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | receptor complex | ITGA2 CUBN LRP1B ITGB2 CEACAM1 LRP1 CD79A CD79B NOTCH1 NOTCH2 NOTCH3 EPHA1 | 2.90e-05 | 581 | 103 | 12 | GO:0043235 |
| GeneOntologyCellularComponent | IgM B cell receptor complex | 7.19e-05 | 3 | 103 | 2 | GO:0071755 | |
| GeneOntologyCellularComponent | side of membrane | FCRL2 TNFRSF9 CYTH1 ITGA2 TNFRSF10C CUBN ITGB2 CEACAM1 LPA LRP1 CD79A CD79B ABCG2 ADGRA3 | 9.86e-05 | 875 | 103 | 14 | GO:0098552 |
| GeneOntologyCellularComponent | laminin-5 complex | 1.43e-04 | 4 | 103 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | adherens junction | 6.40e-04 | 212 | 103 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | B cell receptor complex | 6.60e-04 | 8 | 103 | 2 | GO:0019815 | |
| GeneOntologyCellularComponent | laminin complex | 1.05e-03 | 10 | 103 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | specific granule | 1.18e-03 | 160 | 103 | 5 | GO:0042581 | |
| GeneOntologyCellularComponent | X chromosome | 1.81e-03 | 13 | 103 | 2 | GO:0000805 | |
| GeneOntologyCellularComponent | IgM immunoglobulin complex | 2.42e-03 | 15 | 103 | 2 | GO:0071753 | |
| Domain | EGF_1 | FBLN7 FBLN5 ZAN ADAM18 ADAM15 DNER LAMA5 LAMC2 CUBN SSPOP LRP1B ITGB2 SVEP1 CRB1 TMEFF1 JAG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 USH2A FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 3.59e-38 | 255 | 103 | 34 | PS00022 |
| Domain | EGF_2 | FBLN7 FBLN5 ZAN ADAM18 ADAM15 DNER LAMA5 LAMC2 CUBN SSPOP LRP1B ITGB2 SVEP1 CRB1 TMEFF1 JAG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 EPHA1 | 1.40e-37 | 265 | 103 | 34 | PS01186 |
| Domain | EGF-like_CS | FBLN7 FBLN5 ZAN ADAM18 ADAM15 DNER LAMA5 LAMC2 CUBN LRP1B ITGB2 SVEP1 CRB1 TMEFF1 JAG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 EPHA1 | 3.21e-36 | 261 | 103 | 33 | IPR013032 |
| Domain | EGF_Ca-bd_CS | FBLN7 FBLN5 DNER CUBN LRP1B SVEP1 CRB1 JAG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.11e-35 | 97 | 103 | 25 | IPR018097 |
| Domain | EGF_CA | FBLN7 FBLN5 DNER CUBN LRP1B SVEP1 CRB1 JAG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.98e-35 | 99 | 103 | 25 | PS01187 |
| Domain | EGF-like_dom | FBLN7 FBLN5 ZAN ADAM18 ADAM15 DNER LAMA5 LAMC2 CUBN LRP1B SVEP1 CRB1 TMEFF1 JAG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 FCGBP HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 2.51e-35 | 249 | 103 | 32 | IPR000742 |
| Domain | ASX_HYDROXYL | FBLN7 FBLN5 DNER CUBN LRP1B SVEP1 CRB1 JAG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 2.63e-35 | 100 | 103 | 25 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | FBLN7 FBLN5 DNER CUBN LRP1B SVEP1 CRB1 JAG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.35e-34 | 106 | 103 | 25 | IPR000152 |
| Domain | Growth_fac_rcpt_ | FBLN5 TNFRSF9 DNER LAMA5 LAMC2 CUBN LRP1B SVEP1 CRB1 JAG2 CRELD1 EYS FBLN2 FBN1 FBN2 HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 EPHA1 | 2.10e-33 | 156 | 103 | 27 | IPR009030 |
| Domain | EGF_3 | FBLN7 FBLN5 ZAN ADAM18 ADAM15 DNER CUBN SSPOP LRP1B SVEP1 CRB1 TMEFF1 JAG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 5.56e-33 | 235 | 103 | 30 | PS50026 |
| Domain | EGF | FBLN7 FBLN5 ZAN ADAM15 DNER LAMA5 LAMC2 CUBN LRP1B SVEP1 CRB1 TMEFF1 JAG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 FCGBP SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 5.56e-33 | 235 | 103 | 30 | SM00181 |
| Domain | EGF_CA | FBLN7 FBLN5 DNER CUBN LRP1B SVEP1 CRB1 JAG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 6.56e-33 | 122 | 103 | 25 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | FBLN7 FBLN5 DNER CUBN LRP1B SVEP1 CRB1 JAG2 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.02e-32 | 124 | 103 | 25 | IPR001881 |
| Domain | EGF_CA | FBLN7 FBLN5 CUBN LRP1B SVEP1 JAG2 CRELD1 FBLN2 FBN1 FBN2 HMCN2 SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.85e-29 | 86 | 103 | 21 | PF07645 |
| Domain | EGF | FBLN7 ZAN DNER CUBN LRP1B SVEP1 CRB1 JAG2 SNED1 EYS SCUBE2 HMCN1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 5.15e-24 | 126 | 103 | 20 | PF00008 |
| Domain | hEGF | DNER SVEP1 CRB1 JAG2 SNED1 EYS FBN2 FBN3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.15e-20 | 28 | 103 | 12 | PF12661 |
| Domain | cEGF | 8.21e-17 | 26 | 103 | 10 | IPR026823 | |
| Domain | cEGF | 8.21e-17 | 26 | 103 | 10 | PF12662 | |
| Domain | EGF_extracell | ADAM18 ADAM15 DNER LRP1B ITGB2 SVEP1 JAG2 LTBP2 NOTCH1 NOTCH3 | 9.98e-13 | 60 | 103 | 10 | IPR013111 |
| Domain | EGF_2 | ADAM18 ADAM15 DNER LRP1B ITGB2 SVEP1 JAG2 LTBP2 NOTCH1 NOTCH3 | 9.98e-13 | 60 | 103 | 10 | PF07974 |
| Domain | TB | 9.63e-11 | 7 | 103 | 5 | PF00683 | |
| Domain | - | 2.56e-10 | 8 | 103 | 5 | 3.90.290.10 | |
| Domain | TB | 5.73e-10 | 9 | 103 | 5 | PS51364 | |
| Domain | TB_dom | 5.73e-10 | 9 | 103 | 5 | IPR017878 | |
| Domain | Notch | 8.72e-10 | 4 | 103 | 4 | IPR008297 | |
| Domain | NODP | 8.72e-10 | 4 | 103 | 4 | PF07684 | |
| Domain | Notch_NODP_dom | 8.72e-10 | 4 | 103 | 4 | IPR011656 | |
| Domain | Notch_NOD_dom | 8.72e-10 | 4 | 103 | 4 | IPR010660 | |
| Domain | NOD | 8.72e-10 | 4 | 103 | 4 | PF06816 | |
| Domain | NOD | 8.72e-10 | 4 | 103 | 4 | SM01338 | |
| Domain | NODP | 8.72e-10 | 4 | 103 | 4 | SM01339 | |
| Domain | LNR | 4.34e-09 | 5 | 103 | 4 | PS50258 | |
| Domain | Ig_I-set | FCRL2 ADAMTSL1 OBSCN PAPLN ADAMTSL3 CEACAM1 LRIG2 HMCN2 HMCN1 WFIKKN2 ADGRA3 | 7.99e-09 | 190 | 103 | 11 | IPR013098 |
| Domain | I-set | FCRL2 ADAMTSL1 OBSCN PAPLN ADAMTSL3 CEACAM1 LRIG2 HMCN2 HMCN1 WFIKKN2 ADGRA3 | 7.99e-09 | 190 | 103 | 11 | PF07679 |
| Domain | VWD | 1.93e-08 | 16 | 103 | 5 | SM00216 | |
| Domain | VWF_type-D | 1.93e-08 | 16 | 103 | 5 | IPR001846 | |
| Domain | VWFD | 1.93e-08 | 16 | 103 | 5 | PS51233 | |
| Domain | VWD | 1.93e-08 | 16 | 103 | 5 | PF00094 | |
| Domain | Notch_dom | 3.01e-08 | 7 | 103 | 4 | IPR000800 | |
| Domain | Notch | 3.01e-08 | 7 | 103 | 4 | PF00066 | |
| Domain | NL | 3.01e-08 | 7 | 103 | 4 | SM00004 | |
| Domain | VWC_out | 5.06e-08 | 19 | 103 | 5 | SM00215 | |
| Domain | Ig-like_fold | FCRL2 ADAMTSL1 ICAM3 OBSCN PAPLN ADAMTSL3 CEACAM1 LRIG2 SNED1 HMCN2 HMCN1 WFIKKN2 CD79A CD79B FNDC8 USH2A ADGRA3 EPHA1 | 5.42e-08 | 706 | 103 | 18 | IPR013783 |
| Domain | TSP_1 | 5.42e-08 | 63 | 103 | 7 | PF00090 | |
| Domain | TSP1 | 6.76e-08 | 65 | 103 | 7 | SM00209 | |
| Domain | TSP1_rpt | 6.76e-08 | 65 | 103 | 7 | IPR000884 | |
| Domain | TSP1 | 6.76e-08 | 65 | 103 | 7 | PS50092 | |
| Domain | IGc2 | FCRL2 ADAMTSL1 OBSCN PAPLN ADAMTSL3 CEACAM1 LRIG2 HMCN2 HMCN1 WFIKKN2 CD79A | 7.14e-08 | 235 | 103 | 11 | SM00408 |
| Domain | Ig_sub2 | FCRL2 ADAMTSL1 OBSCN PAPLN ADAMTSL3 CEACAM1 LRIG2 HMCN2 HMCN1 WFIKKN2 CD79A | 7.14e-08 | 235 | 103 | 11 | IPR003598 |
| Domain | IG | FCRL2 ADAMTSL1 ICAM3 OBSCN PAPLN ADAMTSL3 CEACAM1 LRIG2 HMCN2 HMCN1 WFIKKN2 CD79A CD79B ADGRA3 | 7.82e-08 | 421 | 103 | 14 | SM00409 |
| Domain | Ig_sub | FCRL2 ADAMTSL1 ICAM3 OBSCN PAPLN ADAMTSL3 CEACAM1 LRIG2 HMCN2 HMCN1 WFIKKN2 CD79A CD79B ADGRA3 | 7.82e-08 | 421 | 103 | 14 | IPR003599 |
| Domain | - | FCRL2 ADAMTSL1 ICAM3 OBSCN PAPLN ADAMTSL3 CEACAM1 LRIG2 SNED1 HMCN1 WFIKKN2 CD79A CD79B FNDC8 USH2A ADGRA3 EPHA1 | 1.23e-07 | 663 | 103 | 17 | 2.60.40.10 |
| Domain | DUF3454 | 1.63e-07 | 3 | 103 | 3 | PF11936 | |
| Domain | DUF3454_notch | 1.63e-07 | 3 | 103 | 3 | IPR024600 | |
| Domain | DUF3454 | 1.63e-07 | 3 | 103 | 3 | SM01334 | |
| Domain | FBN | 1.63e-07 | 3 | 103 | 3 | IPR011398 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.81e-07 | 24 | 103 | 5 | IPR013273 | |
| Domain | TIL | 4.17e-07 | 12 | 103 | 4 | PF01826 | |
| Domain | C8 | 4.17e-07 | 12 | 103 | 4 | PF08742 | |
| Domain | IG_LIKE | FCRL2 ADAMTSL1 ICAM3 OBSCN PAPLN ADAMTSL3 CEACAM1 LRIG2 HMCN2 HMCN1 WFIKKN2 CD79A CD79B ADGRA3 | 5.07e-07 | 491 | 103 | 14 | PS50835 |
| Domain | Unchr_dom_Cys-rich | 6.00e-07 | 13 | 103 | 4 | IPR014853 | |
| Domain | C8 | 6.00e-07 | 13 | 103 | 4 | SM00832 | |
| Domain | Ig-like_dom | FCRL2 ADAMTSL1 ICAM3 OBSCN PAPLN ADAMTSL3 CEACAM1 LRIG2 HMCN2 HMCN1 WFIKKN2 CD79A CD79B ADGRA3 | 6.76e-07 | 503 | 103 | 14 | IPR007110 |
| Domain | PLAC | 8.37e-07 | 14 | 103 | 4 | PF08686 | |
| Domain | TIL_dom | 8.37e-07 | 14 | 103 | 4 | IPR002919 | |
| Domain | ig | 1.06e-06 | 190 | 103 | 9 | PF00047 | |
| Domain | Immunoglobulin | 1.06e-06 | 190 | 103 | 9 | IPR013151 | |
| Domain | VWC | 2.01e-06 | 38 | 103 | 5 | SM00214 | |
| Domain | PLAC | 3.17e-06 | 19 | 103 | 4 | PS50900 | |
| Domain | PLAC | 3.17e-06 | 19 | 103 | 4 | IPR010909 | |
| Domain | VWF_dom | 3.35e-06 | 42 | 103 | 5 | IPR001007 | |
| Domain | VWFA | 6.06e-06 | 82 | 103 | 6 | PS50234 | |
| Domain | VWA | 6.97e-06 | 84 | 103 | 6 | SM00327 | |
| Domain | Ephrin_rec_like | 1.01e-05 | 25 | 103 | 4 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.01e-05 | 25 | 103 | 4 | IPR011641 | |
| Domain | CCP | 1.18e-05 | 54 | 103 | 5 | SM00032 | |
| Domain | SUSHI | 1.41e-05 | 56 | 103 | 5 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.54e-05 | 57 | 103 | 5 | IPR000436 | |
| Domain | VWF_A | 1.80e-05 | 99 | 103 | 6 | IPR002035 | |
| Domain | Fol_N | 2.60e-05 | 11 | 103 | 3 | IPR003645 | |
| Domain | Ephrin_rec_like | 2.60e-05 | 11 | 103 | 3 | PF07699 | |
| Domain | FOLN | 2.60e-05 | 11 | 103 | 3 | SM00274 | |
| Domain | DUF5050 | 3.01e-05 | 2 | 103 | 2 | IPR032485 | |
| Domain | DUF5050 | 3.01e-05 | 2 | 103 | 2 | PF16472 | |
| Domain | Laminin_EGF | 4.00e-05 | 35 | 103 | 4 | PF00053 | |
| Domain | VWFC_1 | 4.49e-05 | 36 | 103 | 4 | PS01208 | |
| Domain | Kazal_2 | 4.49e-05 | 36 | 103 | 4 | PF07648 | |
| Domain | VWFC_2 | 5.57e-05 | 38 | 103 | 4 | PS50184 | |
| Domain | LAM_G_DOMAIN | 5.57e-05 | 38 | 103 | 4 | PS50025 | |
| Domain | Laminin_EGF | 5.57e-05 | 38 | 103 | 4 | IPR002049 | |
| Domain | Peptidase_M12B_N | 6.19e-05 | 39 | 103 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 6.19e-05 | 39 | 103 | 4 | PF01562 | |
| Domain | DISINTEGRIN_1 | 6.84e-05 | 40 | 103 | 4 | PS00427 | |
| Domain | LDLR_class-A_CS | 6.84e-05 | 40 | 103 | 4 | IPR023415 | |
| Domain | Reprolysin | 6.84e-05 | 40 | 103 | 4 | PF01421 | |
| Domain | Laminin_G_2 | 6.84e-05 | 40 | 103 | 4 | PF02210 | |
| Domain | ADAM_MEPRO | 6.84e-05 | 40 | 103 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 6.84e-05 | 40 | 103 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 6.84e-05 | 40 | 103 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 7.55e-05 | 41 | 103 | 4 | IPR001762 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | ADAMTSL1 ADAMTSL3 SSPOP ADAMTS18 ADAMTS20 MUC5AC NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 3.33e-12 | 68 | 78 | 10 | M27303 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | FBLN5 ADAM15 ICAM3 LAMA5 LAMC2 ITGA2 ITGB2 CEACAM1 FBLN2 FBN1 FBN2 ADAMTS18 LTBP1 LTBP2 FBN3 | 7.67e-11 | 300 | 78 | 15 | M610 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.09e-09 | 37 | 78 | 7 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.92e-09 | 44 | 78 | 7 | M26969 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 4.32e-09 | 5 | 78 | 4 | M27411 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 5.66e-09 | 13 | 78 | 5 | M47423 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | ADAMTSL1 ADAMTSL3 SSPOP ADAMTS18 ADAMTS20 MUC5AC NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 5.87e-09 | 143 | 78 | 10 | M27275 |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 6.37e-09 | 27 | 78 | 6 | M39545 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 1.29e-08 | 6 | 78 | 4 | M27068 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.91e-08 | 32 | 78 | 6 | MM14854 | |
| Pathway | PID_NOTCH_PATHWAY | 3.27e-08 | 59 | 78 | 7 | M17 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 6.66e-08 | 39 | 78 | 6 | MM14601 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTSL1 CUBN ADAMTSL3 SSPOP ADAMTS18 ADAMTS20 MUC5AC NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.19e-07 | 250 | 78 | 11 | M27554 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | FBLN5 ADAM15 ITGA2 ITGB2 CEACAM1 FBLN2 FBN1 FBN2 LPA LTBP1 LTBP2 | 1.64e-07 | 258 | 78 | 11 | MM14572 |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 2.22e-07 | 25 | 78 | 5 | M39713 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 2.78e-07 | 11 | 78 | 4 | M47865 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 4.15e-07 | 12 | 78 | 4 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 4.15e-07 | 12 | 78 | 4 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 5.97e-07 | 13 | 78 | 4 | M47534 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.62e-06 | 5 | 78 | 3 | MM14733 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.26e-06 | 39 | 78 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.26e-06 | 39 | 78 | 5 | MM15165 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.50e-06 | 18 | 78 | 4 | M614 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 4.68e-06 | 45 | 78 | 5 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 5.23e-06 | 46 | 78 | 5 | MM15971 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 5.61e-06 | 7 | 78 | 3 | MM14734 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 5.83e-06 | 47 | 78 | 5 | M7946 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 8.47e-06 | 24 | 78 | 4 | M11190 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.20e-05 | 140 | 78 | 7 | M587 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.61e-05 | 28 | 78 | 4 | M6177 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 2.13e-05 | 61 | 78 | 5 | M39540 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.04e-05 | 109 | 78 | 6 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.37e-05 | 111 | 78 | 6 | M27416 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 3.55e-05 | 34 | 78 | 4 | M39390 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 6.16e-05 | 39 | 78 | 4 | MM14604 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 8.66e-05 | 16 | 78 | 3 | M47424 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 8.91e-05 | 82 | 78 | 5 | MM15922 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.74e-04 | 20 | 78 | 3 | M27881 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.66e-04 | 23 | 78 | 3 | MM14954 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.82e-04 | 66 | 78 | 4 | M18 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 4.90e-04 | 118 | 78 | 5 | M39852 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.94e-04 | 30 | 78 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.94e-04 | 30 | 78 | 3 | M27216 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 6.23e-04 | 7 | 78 | 2 | M27199 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 6.55e-04 | 31 | 78 | 3 | M592 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 8.28e-04 | 8 | 78 | 2 | M47850 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.11e-03 | 37 | 78 | 3 | M39506 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 1.19e-03 | 381 | 78 | 8 | M48063 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.20e-03 | 38 | 78 | 3 | MM14874 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.25e-03 | 85 | 78 | 4 | M16441 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.32e-03 | 10 | 78 | 2 | MM14849 | |
| Pathway | REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN | 1.39e-03 | 40 | 78 | 3 | M48231 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.49e-03 | 41 | 78 | 3 | M27778 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 1.49e-03 | 41 | 78 | 3 | M159 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.61e-03 | 11 | 78 | 2 | M158 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.62e-03 | 154 | 78 | 5 | M39739 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.92e-03 | 12 | 78 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.92e-03 | 12 | 78 | 2 | M22042 | |
| Pathway | REACTOME_SYNTHESIS_OF_PE | 1.92e-03 | 12 | 78 | 2 | MM14586 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 1.92e-03 | 12 | 78 | 2 | MM15447 | |
| Pathway | REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA | 1.92e-03 | 12 | 78 | 2 | MM15105 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 1.92e-03 | 12 | 78 | 2 | MM15476 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.97e-03 | 161 | 78 | 5 | M39770 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 2.04e-03 | 97 | 78 | 4 | MM15926 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.22e-03 | 47 | 78 | 3 | M646 | |
| Pathway | REACTOME_SYNTHESIS_OF_PE | 2.27e-03 | 13 | 78 | 2 | M656 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 2.36e-03 | 101 | 78 | 4 | M39448 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.39e-03 | 246 | 78 | 6 | M10189 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.50e-03 | 49 | 78 | 3 | M618 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 2.63e-03 | 14 | 78 | 2 | M619 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 3.03e-03 | 15 | 78 | 2 | M27202 | |
| Pathway | REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA | 3.03e-03 | 15 | 78 | 2 | M27360 | |
| Pathway | REACTOME_HEME_DEGRADATION | 3.03e-03 | 15 | 78 | 2 | M27060 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 3.03e-03 | 15 | 78 | 2 | MM15697 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.65e-03 | 114 | 78 | 4 | MM14571 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 3.90e-03 | 17 | 78 | 2 | M39389 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.24e-03 | 59 | 78 | 3 | M27218 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 4.26e-03 | 119 | 78 | 4 | M607 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 4.37e-03 | 18 | 78 | 2 | MM14775 | |
| Pathway | WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY | 4.37e-03 | 18 | 78 | 2 | M42546 | |
| Pathway | WP_STATIN_PATHWAY | 4.86e-03 | 19 | 78 | 2 | MM15868 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 4.86e-03 | 19 | 78 | 2 | MM15594 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 4.86e-03 | 19 | 78 | 2 | MM14612 | |
| Pathway | WP_ETHER_LIPID_BIOSYNTHESIS | 5.38e-03 | 20 | 78 | 2 | M46451 | |
| Pathway | REACTOME_HEME_DEGRADATION | 5.38e-03 | 20 | 78 | 2 | MM14721 | |
| Pubmed | FBLN5 ADAMTSL1 CTSC LAMA5 SSPOP CRELD1 FBLN2 FBN1 FBN2 HMCN2 HMCN1 LPA LTBP1 LTBP2 | 2.11e-16 | 175 | 104 | 14 | 28071719 | |
| Pubmed | FBLN5 ADAMTSL1 LAMA5 PAPLN LAMC2 FBLN2 FBN1 HMCN2 HMCN1 LPA LTBP1 LTBP2 | 1.19e-13 | 167 | 104 | 12 | 22159717 | |
| Pubmed | 4.53e-12 | 7 | 104 | 5 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 4.53e-12 | 7 | 104 | 5 | 12846471 | |
| Pubmed | 1.21e-11 | 8 | 104 | 5 | 9858718 | ||
| Pubmed | 2.71e-11 | 9 | 104 | 5 | 11118901 | ||
| Pubmed | 2.71e-11 | 9 | 104 | 5 | 16245338 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 5.40e-11 | 10 | 104 | 5 | 23665443 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FBLN5 ADAM15 CTSC DNER LAMA5 GRN HMGCR ITGA2 LRP1B JAG2 LRIG2 CRELD1 FBN1 FBN2 LRP1 LTBP1 LTBP2 NOTCH1 NOTCH2 ADGRA3 NOTCH3 | 5.65e-11 | 1201 | 104 | 21 | 35696571 |
| Pubmed | 6.95e-11 | 75 | 104 | 8 | 20637190 | ||
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 24145721 | ||
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 7.54e-11 | 4 | 104 | 4 | 19404845 | |
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 28669409 | ||
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 11401408 | ||
| Pubmed | Functional conservation of mouse Notch receptor family members. | 7.54e-11 | 4 | 104 | 4 | 8898100 | |
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 23444212 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 7.54e-11 | 4 | 104 | 4 | 17920003 | |
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 7.54e-11 | 4 | 104 | 4 | 28061457 | |
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 11466531 | ||
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 24151014 | ||
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 7.54e-11 | 4 | 104 | 4 | 10194420 | |
| Pubmed | 7.54e-11 | 4 | 104 | 4 | 11459941 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 7.54e-11 | 4 | 104 | 4 | 18184405 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 7.54e-11 | 4 | 104 | 4 | 15917835 | |
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 9.88e-11 | 11 | 104 | 5 | 16607638 | |
| Pubmed | 9.88e-11 | 11 | 104 | 5 | 10878608 | ||
| Pubmed | 9.88e-11 | 11 | 104 | 5 | 12866128 | ||
| Pubmed | 1.69e-10 | 12 | 104 | 5 | 15465494 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 2.74e-10 | 13 | 104 | 5 | 11578869 | |
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 2.78e-10 | 29 | 104 | 6 | 21402740 | |
| Pubmed | 3.76e-10 | 5 | 104 | 4 | 11101851 | ||
| Pubmed | 3.76e-10 | 5 | 104 | 4 | 21124806 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 3.76e-10 | 5 | 104 | 4 | 15064243 | |
| Pubmed | 3.76e-10 | 5 | 104 | 4 | 23675950 | ||
| Pubmed | 3.76e-10 | 5 | 104 | 4 | 15882997 | ||
| Pubmed | 4.25e-10 | 14 | 104 | 5 | 14757642 | ||
| Pubmed | 6.36e-10 | 15 | 104 | 5 | 12971992 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 9.23e-10 | 16 | 104 | 5 | 12617809 | |
| Pubmed | 9.23e-10 | 16 | 104 | 5 | 17273555 | ||
| Pubmed | 9.23e-10 | 16 | 104 | 5 | 10842072 | ||
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 9.35e-10 | 35 | 104 | 6 | 21252157 | |
| Pubmed | 1.13e-09 | 6 | 104 | 4 | 9111338 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 1.13e-09 | 6 | 104 | 4 | 12244553 | |
| Pubmed | 1.13e-09 | 6 | 104 | 4 | 18299578 | ||
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 1.13e-09 | 6 | 104 | 4 | 15019995 | |
| Pubmed | Notch controls the magnitude of T helper cell responses by promoting cellular longevity. | 1.13e-09 | 6 | 104 | 4 | 22615412 | |
| Pubmed | 1.13e-09 | 6 | 104 | 4 | 20870902 | ||
| Pubmed | 1.13e-09 | 6 | 104 | 4 | 19349279 | ||
| Pubmed | 1.13e-09 | 6 | 104 | 4 | 19503073 | ||
| Pubmed | Notch lineages and activity in intestinal stem cells determined by a new set of knock-in mice. | 1.13e-09 | 6 | 104 | 4 | 21991352 | |
| Pubmed | 1.30e-09 | 17 | 104 | 5 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 1.30e-09 | 17 | 104 | 5 | 15821257 | |
| Pubmed | 1.80e-09 | 18 | 104 | 5 | 18093989 | ||
| Pubmed | 1.80e-09 | 18 | 104 | 5 | 15689374 | ||
| Pubmed | 2.44e-09 | 19 | 104 | 5 | 16518823 | ||
| Pubmed | 2.55e-09 | 41 | 104 | 6 | 22675208 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 10383933 | ||
| Pubmed | Murine notch homologs (N1-4) undergo presenilin-dependent proteolysis. | 2.62e-09 | 7 | 104 | 4 | 11518718 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 16169548 | ||
| Pubmed | 4.25e-09 | 21 | 104 | 5 | 28656980 | ||
| Pubmed | Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. | 4.25e-09 | 21 | 104 | 5 | 14702043 | |
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 5.23e-09 | 8 | 104 | 4 | 22652674 | |
| Pubmed | 5.23e-09 | 8 | 104 | 4 | 11044610 | ||
| Pubmed | 5.23e-09 | 8 | 104 | 4 | 22156581 | ||
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 5.23e-09 | 8 | 104 | 4 | 12242716 | |
| Pubmed | 5.49e-09 | 22 | 104 | 5 | 34998785 | ||
| Pubmed | 6.99e-09 | 23 | 104 | 5 | 14701881 | ||
| Pubmed | Rbpj regulates development of prosensory cells in the mammalian inner ear. | 8.81e-09 | 24 | 104 | 5 | 21420948 | |
| Pubmed | 9.40e-09 | 9 | 104 | 4 | 12370315 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.36e-08 | 26 | 104 | 5 | 34189436 | |
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 1.36e-08 | 26 | 104 | 5 | 19369401 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | FBLN5 WWP1 LAMA5 GRN JAG2 CRELD1 FBLN2 FBN1 LTBP1 L3MBTL3 NOTCH1 NOTCH2 NOTCH3 | 1.37e-08 | 560 | 104 | 13 | 21653829 |
| Pubmed | 1.56e-08 | 10 | 104 | 4 | 33915108 | ||
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 1.66e-08 | 27 | 104 | 5 | 21791528 | |
| Pubmed | 2.43e-08 | 29 | 104 | 5 | 25535917 | ||
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 2.45e-08 | 11 | 104 | 4 | 9187150 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 2.45e-08 | 11 | 104 | 4 | 15499562 | |
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 2.60e-08 | 3 | 104 | 3 | 25846406 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 8645602 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 27697639 | ||
| Pubmed | Differential expression of Notch genes in human osteoblastic cells. | 2.60e-08 | 3 | 104 | 3 | 11836628 | |
| Pubmed | Notch signaling: cell fate control and signal integration in development. | 2.60e-08 | 3 | 104 | 3 | 10221902 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 7615640 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 7918097 | ||
| Pubmed | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 2.60e-08 | 3 | 104 | 3 | 21471519 | |
| Pubmed | Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. | 2.60e-08 | 3 | 104 | 3 | 18458347 | |
| Pubmed | Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. | 2.60e-08 | 3 | 104 | 3 | 29767458 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 7698746 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 17293099 | ||
| Pubmed | The Notch-mediated circuitry in the evolution and generation of new cell lineages: the tooth model. | 2.60e-08 | 3 | 104 | 3 | 37330998 | |
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 2.91e-08 | 30 | 104 | 5 | 24552588 | |
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 2.91e-08 | 30 | 104 | 5 | 32882513 | |
| Pubmed | 3.47e-08 | 31 | 104 | 5 | 37573008 | ||
| Pubmed | 3.67e-08 | 12 | 104 | 4 | 10952889 | ||
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 5.28e-08 | 13 | 104 | 4 | 31202705 | |
| Pubmed | A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. | 5.28e-08 | 13 | 104 | 4 | 32929274 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 5.28e-08 | 13 | 104 | 4 | 20558824 | |
| Pubmed | 5.63e-08 | 34 | 104 | 5 | 21311046 | ||
| Pubmed | Cell-fate transition and determination analysis of mouse male germ cells throughout development. | 7.38e-08 | 14 | 104 | 4 | 34824237 | |
| Interaction | NTN5 interactions | 1.87e-15 | 24 | 102 | 9 | int:NTN5 | |
| Interaction | ZFP41 interactions | 1.12e-11 | 57 | 102 | 9 | int:ZFP41 | |
| Interaction | FBXO2 interactions | CACNA2D2 LAMA5 LAMC2 GRN ITGA2 LRP1B JAG2 LRIG2 SNED1 FBN1 FBN2 IL17RA NOTCH1 NOTCH2 ADGRA3 NOTCH3 EPHA1 | 2.59e-11 | 411 | 102 | 17 | int:FBXO2 |
| Interaction | IGFL3 interactions | 1.45e-10 | 75 | 102 | 9 | int:IGFL3 | |
| Interaction | ZNF408 interactions | FBLN5 GRN LRP1B CRELD1 FBLN2 FBN1 FBN2 LTBP1 LTBP2 NOTCH2 NOTCH3 | 1.86e-10 | 145 | 102 | 11 | int:ZNF408 |
| Interaction | FBN2 interactions | 1.30e-09 | 65 | 102 | 8 | int:FBN2 | |
| Interaction | BRICD5 interactions | CACNA2D2 ADAM15 ICAM3 ITGA2 JAG2 LRIG2 CD79A NOTCH2 ADGRA3 EPHA1 | 5.36e-08 | 194 | 102 | 10 | int:BRICD5 |
| Interaction | ZNF324 interactions | 1.15e-07 | 46 | 102 | 6 | int:ZNF324 | |
| Interaction | EGFL7 interactions | 1.24e-07 | 77 | 102 | 7 | int:EGFL7 | |
| Interaction | PRG2 interactions | CACNA2D2 ADAM15 LAMA5 LAMC2 JAG2 FBN2 IL17RA NOTCH1 ZMYM3 NOTCH2 NOTCH3 | 2.13e-07 | 285 | 102 | 11 | int:PRG2 |
| Interaction | MFAP5 interactions | 2.44e-07 | 52 | 102 | 6 | int:MFAP5 | |
| Interaction | LTBP1 interactions | 4.26e-07 | 92 | 102 | 7 | int:LTBP1 | |
| Interaction | ZNF74 interactions | 7.45e-07 | 34 | 102 | 5 | int:ZNF74 | |
| Interaction | LGALS1 interactions | RNF113A LAMA5 GRN ITGA2 TNFRSF10C JAG2 SUSD2 NOTCH1 NOTCH2 ADGRA3 NOTCH3 | 9.64e-07 | 332 | 102 | 11 | int:LGALS1 |
| Interaction | MAML2 interactions | 1.40e-06 | 17 | 102 | 4 | int:MAML2 | |
| Interaction | HOXA1 interactions | FBLN5 KPRP LAMA5 GRN JAG2 CRELD1 FBLN2 FBN1 LTBP1 NOTCH1 NOTCH3 | 1.90e-06 | 356 | 102 | 11 | int:HOXA1 |
| Interaction | SFTPC interactions | 1.92e-06 | 222 | 102 | 9 | int:SFTPC | |
| Interaction | MAML3 interactions | 2.82e-06 | 20 | 102 | 4 | int:MAML3 | |
| Interaction | ZNF627 interactions | 2.82e-06 | 20 | 102 | 4 | int:ZNF627 | |
| Interaction | ZDHHC15 interactions | 3.38e-06 | 125 | 102 | 7 | int:ZDHHC15 | |
| Interaction | CFC1 interactions | 3.56e-06 | 126 | 102 | 7 | int:CFC1 | |
| Interaction | ZNF594 interactions | 4.34e-06 | 7 | 102 | 3 | int:ZNF594 | |
| Interaction | FBN1 interactions | 5.88e-06 | 51 | 102 | 5 | int:FBN1 | |
| Interaction | EDDM3B interactions | 1.32e-05 | 60 | 102 | 5 | int:EDDM3B | |
| Interaction | HRG interactions | 1.68e-05 | 63 | 102 | 5 | int:HRG | |
| Interaction | EDN3 interactions | 1.83e-05 | 108 | 102 | 6 | int:EDN3 | |
| Interaction | FBLN2 interactions | 2.10e-05 | 66 | 102 | 5 | int:FBLN2 | |
| Interaction | NOTCH3 interactions | 2.36e-05 | 113 | 102 | 6 | int:NOTCH3 | |
| Interaction | ZNF696 interactions | 2.44e-05 | 68 | 102 | 5 | int:ZNF696 | |
| Interaction | MFAP2 interactions | 2.68e-05 | 12 | 102 | 3 | int:MFAP2 | |
| Interaction | ZNF709 interactions | 3.47e-05 | 13 | 102 | 3 | int:ZNF709 | |
| Interaction | ADAMTSL1 interactions | 3.47e-05 | 13 | 102 | 3 | int:ADAMTSL1 | |
| Interaction | ZNF235 interactions | 3.47e-05 | 13 | 102 | 3 | int:ZNF235 | |
| Interaction | SDF2L1 interactions | 3.78e-05 | 322 | 102 | 9 | int:SDF2L1 | |
| Interaction | DLL1 interactions | 4.00e-05 | 38 | 102 | 4 | int:DLL1 | |
| Interaction | IGSF5 interactions | 4.40e-05 | 14 | 102 | 3 | int:IGSF5 | |
| Interaction | ATN1 interactions | 4.65e-05 | 187 | 102 | 7 | int:ATN1 | |
| Interaction | JAG1 interactions | 5.42e-05 | 41 | 102 | 4 | int:JAG1 | |
| Interaction | ZNF628 interactions | 6.72e-05 | 16 | 102 | 3 | int:ZNF628 | |
| Interaction | SIRPD interactions | 7.57e-05 | 86 | 102 | 5 | int:SIRPD | |
| Interaction | ITGAD interactions | 8.57e-05 | 46 | 102 | 4 | int:ITGAD | |
| Interaction | SLURP1 interactions | 9.19e-05 | 144 | 102 | 6 | int:SLURP1 | |
| Interaction | ZNF865 interactions | 9.33e-05 | 47 | 102 | 4 | int:ZNF865 | |
| Interaction | CLEC2B interactions | 1.03e-04 | 147 | 102 | 6 | int:CLEC2B | |
| Interaction | WNT3A interactions | 1.10e-04 | 49 | 102 | 4 | int:WNT3A | |
| Interaction | PRG3 interactions | 1.10e-04 | 49 | 102 | 4 | int:PRG3 | |
| Interaction | FOXD4L6 interactions | 1.10e-04 | 49 | 102 | 4 | int:FOXD4L6 | |
| Interaction | CCN6 interactions | 1.15e-04 | 19 | 102 | 3 | int:CCN6 | |
| Interaction | ZNF358 interactions | 1.15e-04 | 19 | 102 | 3 | int:ZNF358 | |
| Interaction | ZNF224 interactions | 1.35e-04 | 20 | 102 | 3 | int:ZNF224 | |
| Interaction | BTNL2 interactions | 1.38e-04 | 155 | 102 | 6 | int:BTNL2 | |
| Interaction | NOTCH4 interactions | 1.57e-04 | 21 | 102 | 3 | int:NOTCH4 | |
| Interaction | ZNF77 interactions | 1.81e-04 | 22 | 102 | 3 | int:ZNF77 | |
| Interaction | CASR interactions | 1.81e-04 | 22 | 102 | 3 | int:CASR | |
| Interaction | ZNF431 interactions | 1.81e-04 | 22 | 102 | 3 | int:ZNF431 | |
| Interaction | ZNF444 interactions | 2.03e-04 | 106 | 102 | 5 | int:ZNF444 | |
| Interaction | ZNF282 interactions | 2.07e-04 | 23 | 102 | 3 | int:ZNF282 | |
| Interaction | CD209 interactions | 2.07e-04 | 23 | 102 | 3 | int:CD209 | |
| Interaction | SENP5 interactions | 2.27e-04 | 59 | 102 | 4 | int:SENP5 | |
| Interaction | ZNF765 interactions | 2.36e-04 | 24 | 102 | 3 | int:ZNF765 | |
| Interaction | MANEA interactions | 2.43e-04 | 60 | 102 | 4 | int:MANEA | |
| Interaction | NUFIP2 interactions | 2.68e-04 | 417 | 102 | 9 | int:NUFIP2 | |
| Interaction | NOTCH2 interactions | 2.97e-04 | 423 | 102 | 9 | int:NOTCH2 | |
| Interaction | ZNF320 interactions | 3.37e-04 | 27 | 102 | 3 | int:ZNF320 | |
| Interaction | EMILIN2 interactions | 3.37e-04 | 27 | 102 | 3 | int:EMILIN2 | |
| Interaction | DNASE1L1 interactions | 3.62e-04 | 120 | 102 | 5 | int:DNASE1L1 | |
| Interaction | DLL4 interactions | 3.75e-04 | 6 | 102 | 2 | int:DLL4 | |
| Interaction | LYPD4 interactions | 4.05e-04 | 123 | 102 | 5 | int:LYPD4 | |
| Interaction | CACNA1A interactions | 4.05e-04 | 123 | 102 | 5 | int:CACNA1A | |
| Interaction | ELN interactions | 4.18e-04 | 29 | 102 | 3 | int:ELN | |
| Interaction | ZNF430 interactions | 4.18e-04 | 29 | 102 | 3 | int:ZNF430 | |
| Interaction | CBLN4 interactions | 4.69e-04 | 127 | 102 | 5 | int:CBLN4 | |
| Interaction | ZSCAN21 interactions | 4.87e-04 | 128 | 102 | 5 | int:ZSCAN21 | |
| Interaction | FBLN1 interactions | 5.04e-04 | 129 | 102 | 5 | int:FBLN1 | |
| Interaction | ZNF664 interactions | 5.10e-04 | 31 | 102 | 3 | int:ZNF664 | |
| Interaction | MAML1 interactions | 5.15e-04 | 73 | 102 | 4 | int:MAML1 | |
| Interaction | ZNF253 interactions | 5.24e-04 | 7 | 102 | 2 | int:ZNF253 | |
| Interaction | ZNF101 interactions | 6.15e-04 | 33 | 102 | 3 | int:ZNF101 | |
| Interaction | MBD1 interactions | 6.30e-04 | 77 | 102 | 4 | int:MBD1 | |
| Interaction | ST14 interactions | 6.49e-04 | 207 | 102 | 6 | int:ST14 | |
| Interaction | ZNF707 interactions | 6.95e-04 | 79 | 102 | 4 | int:ZNF707 | |
| Interaction | DNER interactions | 6.96e-04 | 8 | 102 | 2 | int:DNER | |
| Interaction | TMEM106A interactions | 7.72e-04 | 214 | 102 | 6 | int:TMEM106A | |
| Interaction | ZNF724 interactions | 7.96e-04 | 36 | 102 | 3 | int:ZNF724 | |
| Interaction | BCAN interactions | 7.96e-04 | 36 | 102 | 3 | int:BCAN | |
| Interaction | B3GLCT interactions | 7.96e-04 | 36 | 102 | 3 | int:B3GLCT | |
| Interaction | ZNF136 interactions | 7.96e-04 | 36 | 102 | 3 | int:ZNF136 | |
| Interaction | SLC22A23 interactions | 8.63e-04 | 37 | 102 | 3 | int:SLC22A23 | |
| Interaction | ALG10B interactions | 8.92e-04 | 9 | 102 | 2 | int:ALG10B | |
| Interaction | ZNF480 interactions | 8.92e-04 | 9 | 102 | 2 | int:ZNF480 | |
| Interaction | ZKSCAN2 interactions | 8.92e-04 | 9 | 102 | 2 | int:ZKSCAN2 | |
| Interaction | PSEN2 interactions | 9.56e-04 | 86 | 102 | 4 | int:PSEN2 | |
| Interaction | NID2 interactions | 9.56e-04 | 86 | 102 | 4 | int:NID2 | |
| GeneFamily | Fibulins | 4.49e-11 | 8 | 71 | 5 | 556 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | ADAMTSL1 OBSCN PAPLN ADAMTSL3 LRIG2 HMCN2 HMCN1 WFIKKN2 ADGRA3 | 1.31e-08 | 161 | 71 | 9 | 593 |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | FCRL2 TNFRSF9 ICAM3 ITGA2 TNFRSF10C ITGB2 CEACAM1 LRP1 CD79A CD79B IL17RA ABCG2 | 3.90e-08 | 394 | 71 | 12 | 471 |
| GeneFamily | ADAMTS like | 2.01e-06 | 7 | 71 | 3 | 947 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.89e-06 | 57 | 71 | 5 | 1179 | |
| GeneFamily | Low density lipoprotein receptors | 1.61e-05 | 13 | 71 | 3 | 634 | |
| GeneFamily | Lipins | 4.55e-05 | 3 | 71 | 2 | 1043 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 9.08e-05 | 4 | 71 | 2 | 628 | |
| GeneFamily | Fibronectin type III domain containing | 4.15e-04 | 160 | 71 | 5 | 555 | |
| GeneFamily | Immunoglobulin like domain containing | 9.69e-04 | 193 | 71 | 5 | 594 | |
| GeneFamily | Laminin subunits | 9.78e-04 | 12 | 71 | 2 | 626 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.49e-03 | 19 | 71 | 2 | 50 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.01e-03 | 27 | 71 | 2 | 47 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 5.76e-03 | 29 | 71 | 2 | 782 | |
| GeneFamily | Ankyrin repeat domain containing | 1.51e-02 | 242 | 71 | 4 | 403 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FBLN7 FBLN5 LAMA5 PAPLN LAMC2 SSPOP SVEP1 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 HMCN2 HMCN1 LTBP1 LTBP2 FNDC8 USH2A FBN3 | 8.22e-23 | 196 | 104 | 20 | M3008 |
| Coexpression | NABA_MATRISOME | FBLN7 FBLN5 ADAMTSL1 ADAM18 ADAM15 CTSC LAMA5 PAPLN LAMC2 ADAMTSL3 SSPOP SVEP1 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 PRG3 HMCN2 SCUBE2 HMCN1 LPA WFIKKN2 ADAMTS18 ADAMTS20 LTBP1 LTBP2 FNDC8 USH2A MUC5AC FBN3 IL9 | 2.13e-21 | 1026 | 104 | 33 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | FBLN7 FBLN5 LAMA5 PAPLN LAMC2 SSPOP SVEP1 SNED1 CRELD1 EYS FBLN2 FBN1 FBN2 PRG3 HMCN2 HMCN1 LTBP1 LTBP2 FNDC8 USH2A FBN3 | 2.98e-21 | 275 | 104 | 21 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FBLN7 FBLN5 LAMA5 PAPLN LAMC2 SSPOP SVEP1 SNED1 CRELD1 FBLN2 FBN1 FBN2 HMCN2 HMCN1 LTBP1 LTBP2 FNDC8 | 1.77e-18 | 191 | 104 | 17 | MM17059 |
| Coexpression | NABA_MATRISOME | FBLN7 FBLN5 ADAMTSL1 ADAM18 ADAM15 CTSC LAMA5 PAPLN LAMC2 ADAMTSL3 SSPOP SVEP1 SNED1 CRELD1 FBLN2 FBN1 FBN2 PRG3 HMCN2 SCUBE2 HMCN1 LPA WFIKKN2 ADAMTS18 ADAMTS20 LTBP1 LTBP2 FNDC8 MUC5AC IL9 | 1.79e-18 | 1008 | 104 | 30 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | FBLN7 FBLN5 LAMA5 PAPLN LAMC2 SSPOP SVEP1 SNED1 CRELD1 FBLN2 FBN1 FBN2 PRG3 HMCN2 HMCN1 LTBP1 LTBP2 FNDC8 | 2.90e-17 | 270 | 104 | 18 | MM17057 |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.76e-09 | 16 | 104 | 5 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.76e-09 | 16 | 104 | 5 | M2207 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 5.26e-07 | 40 | 104 | 5 | M5887 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.38e-06 | 200 | 104 | 8 | M5930 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 3.77e-06 | 59 | 104 | 5 | M47989 | |
| Coexpression | NABA_ECM_REGULATORS | 5.00e-06 | 238 | 104 | 8 | M3468 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | FBLN5 OBSCN LAMA5 ABLIM3 SNED1 FBN1 SCUBE2 LRP1 LTBP2 NOTCH3 NOTCH4 | 5.41e-06 | 505 | 104 | 11 | M39167 |
| Coexpression | NABA_ECM_REGULATORS | 5.65e-06 | 242 | 104 | 8 | MM17062 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 5.99e-06 | 173 | 104 | 7 | M2385 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 1.03e-05 | 188 | 104 | 7 | MM1071 | |
| Coexpression | RPS14_DN.V1_UP | 1.14e-05 | 191 | 104 | 7 | M2816 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_UP | 1.40e-05 | 197 | 104 | 7 | M8752 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 1.90e-05 | 286 | 104 | 8 | M45746 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTSL1 ADAM18 ADAM15 CTSC ADAMTSL3 SCUBE2 LPA WFIKKN2 ADAMTS18 ADAMTS20 MUC5AC IL9 | 3.68e-05 | 738 | 104 | 12 | MM17058 |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 4.33e-05 | 235 | 104 | 7 | M5311 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTSL1 ADAM18 ADAM15 CTSC ADAMTSL3 SCUBE2 LPA WFIKKN2 ADAMTS18 ADAMTS20 MUC5AC IL9 | 4.36e-05 | 751 | 104 | 12 | M5885 |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 4.68e-05 | 50 | 104 | 4 | M1259 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 5.47e-05 | 52 | 104 | 4 | MM1118 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 6.59e-05 | 20 | 104 | 3 | MM17053 | |
| Coexpression | MOHANKUMAR_HOXA1_TARGETS_DN | 7.41e-05 | 176 | 104 | 6 | M9032 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 8.37e-05 | 261 | 104 | 7 | M1834 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 8.71e-05 | 355 | 104 | 8 | M45758 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | FBLN7 CACNA2D2 LAMC2 ABLIM3 SVEP1 SNED1 FBLN2 SCUBE2 HMCN1 MTUS1 ADAMTS18 IL17RA SYT13 NOTCH1 | 8.85e-05 | 1074 | 104 | 14 | M1941 |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | 9.41e-05 | 359 | 104 | 8 | M15193 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 9.69e-05 | 115 | 104 | 5 | M45752 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.01e-04 | 23 | 104 | 3 | M48001 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 1.05e-04 | 117 | 104 | 5 | M39300 | |
| Coexpression | ONDER_CDH1_TARGETS_2_DN | 1.14e-04 | 473 | 104 | 9 | M4306 | |
| Coexpression | GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP | 1.30e-04 | 195 | 104 | 6 | M4658 | |
| Coexpression | LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS | 1.31e-04 | 25 | 104 | 3 | M1478 | |
| Coexpression | GSE4142_NAIVE_VS_GC_BCELL_UP | 1.45e-04 | 199 | 104 | 6 | M6375 | |
| Coexpression | LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS | 1.48e-04 | 26 | 104 | 3 | MM639 | |
| Coexpression | GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN | 1.49e-04 | 200 | 104 | 6 | M5099 | |
| Coexpression | GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 1.49e-04 | 200 | 104 | 6 | M9549 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 1.59e-04 | 610 | 104 | 10 | M3854 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.66e-04 | 27 | 104 | 3 | M47994 | |
| Coexpression | TRAVAGLINI_LUNG_ARTERY_CELL | 1.79e-04 | 131 | 104 | 5 | M41662 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL | 1.96e-04 | 72 | 104 | 4 | M45791 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 2.06e-04 | 135 | 104 | 5 | M5825 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 2.20e-04 | 137 | 104 | 5 | M40313 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_MESENCHYMAL | 2.27e-04 | 216 | 104 | 6 | M2122 | |
| Coexpression | HORIUCHI_WTAP_TARGETS_UP | 2.37e-04 | 309 | 104 | 7 | M1973 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 2.64e-04 | 650 | 104 | 10 | MM1042 | |
| Coexpression | KRAS.300_UP.V1_UP | 2.69e-04 | 143 | 104 | 5 | M2875 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 2.77e-04 | 32 | 104 | 3 | M5903 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 3.21e-04 | 325 | 104 | 7 | M39053 | |
| Coexpression | KESHELAVA_MULTIPLE_DRUG_RESISTANCE | 3.23e-04 | 82 | 104 | 4 | M12618 | |
| Coexpression | ONDER_CDH1_SIGNALING_VIA_CTNNB1 | 3.54e-04 | 84 | 104 | 4 | M15484 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 3.62e-04 | 35 | 104 | 3 | MM17054 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.62e-04 | 35 | 104 | 3 | M11788 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | CTSC ITGA2 FBN1 HMCN1 SUSD2 LTBP1 LTBP2 NOTCH1 NOTCH2 NOTCH3 | 3.82e-04 | 681 | 104 | 10 | M39175 |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.94e-04 | 36 | 104 | 3 | MM1212 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 4.30e-04 | 8 | 104 | 2 | M9884 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS | 4.41e-04 | 89 | 104 | 4 | M40280 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_MELANOMA | 4.63e-04 | 38 | 104 | 3 | M47982 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 4.90e-04 | 163 | 104 | 5 | M12112 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_1DY_UP | 5.00e-04 | 39 | 104 | 3 | M41137 | |
| Coexpression | SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP | 5.51e-04 | 9 | 104 | 2 | M18679 | |
| Coexpression | KOMMAGANI_TP63_GAMMA_TARGETS | 5.51e-04 | 9 | 104 | 2 | M9630 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 5.70e-04 | 257 | 104 | 6 | M13867 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 5.80e-04 | 41 | 104 | 3 | M47988 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4 | ITGA2 TNFRSF10C CUBN ADAMTSL3 ABLIM3 CEACAM1 SNED1 MTUS1 ADAMTS18 INSYN2B LTBP2 NOTCH4 | 9.11e-07 | 428 | 101 | 12 | JC_hmvEC_1000_K4 |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 1.00e-05 | 219 | 101 | 8 | JC_hmvEC_500_K1 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | FBLN7 FBLN5 ADAMTSL1 DNER SSPOP LRP1B SVEP1 CRB1 TG LRRC46 FBLN2 FBN1 FBN2 HMCN1 ADAMTS18 INSYN2B LTBP2 | 1.49e-05 | 1094 | 101 | 17 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000 | ADAMTSL1 PAPLN LAMC2 ITGA2 TNFRSF10C CUBN ADAMTSL3 ABLIM3 CEACAM1 JAG2 SNED1 MTUS1 ADAMTS18 INSYN2B LTBP2 NOTCH4 | 1.70e-05 | 990 | 101 | 16 | JC_hmvEC_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_500 | FBLN5 ADAMTSL1 ITGA2 ABLIM3 SVEP1 SNED1 FBN1 SUSD2 ADAMTS18 INSYN2B LTBP2 | 2.29e-05 | 493 | 101 | 11 | PCBC_ctl_CardiacMyocyte_500 |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500 | ADAMTSL1 PAPLN LAMC2 ITGA2 ADAMTSL3 ABLIM3 CEACAM1 JAG2 ADAMTS18 LTBP2 NOTCH4 | 2.38e-05 | 495 | 101 | 11 | JC_hmvEC_500 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardioEndothel_top-relative-expression-ranked_500 | ADAMTSL1 LAMC2 TNFRSF10C CUBN ABLIM3 JAG2 MTUS1 ADAMTS18 INSYN2B LTBP2 NOTCH4 | 2.38e-05 | 495 | 101 | 11 | PCBC_ctl_CardioEndothel_500 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.53e-05 | 261 | 101 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | FBLN7 GRN ITGA2 TNFRSF10C CUBN ADAMTSL3 ABLIM3 PCGF5 CEACAM1 SNED1 MTUS1 ADAMTS18 INSYN2B LTBP2 NOTCH4 | 3.54e-05 | 936 | 101 | 15 | JC_hmvEC_2500_K1 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardioEndothel_top-relative-expression-ranked_1000 | FBLN7 ADAMTSL1 LAMC2 ITGA2 TNFRSF10C CUBN ABLIM3 JAG2 SNED1 MTUS1 ADAMTS18 INSYN2B LTBP2 CSMD1 NOTCH4 | 5.83e-05 | 978 | 101 | 15 | PCBC_ctl_CardioEndothel_1000 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 5.94e-05 | 281 | 101 | 8 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 5.94e-05 | 281 | 101 | 8 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_PulmonMicrovasc_top-relative-expression-ranked_1000 | ADAMTSL1 PAPLN ITGA2 TNFRSF10C CUBN ADAMTSL3 ABLIM3 CEACAM1 JAG2 SNED1 MTUS1 ADAMTS18 INSYN2B LTBP2 NOTCH4 | 6.03e-05 | 981 | 101 | 15 | PCBC_ctl_PulmonMicrovasc_1000 |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | FBLN5 ADAM15 LAMA5 ITGA2 CEACAM1 FBLN2 SUSD2 LTBP2 ABCG2 NOTCH4 | 6.35e-05 | 456 | 101 | 10 | GSM777032_500 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | FBLN5 ADAM15 LAMA5 ITGA2 CEACAM1 FBLN2 SUSD2 LTBP2 ABCG2 NOTCH4 | 6.71e-05 | 459 | 101 | 10 | GSM777037_500 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.71e-05 | 369 | 101 | 9 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#1_top-relative-expression-ranked_500 | 1.18e-04 | 53 | 101 | 4 | gudmap_kidney_P0_JuxtaGlom_Ren1_k1_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 1.51e-04 | 240 | 101 | 7 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | FBLN5 ADAMTSL1 DNER OLFM4 CUBN SVEP1 CRB1 FBN1 HMCN1 ADAMTS18 ADAMTS20 INSYN2B LTBP2 FBN3 | 1.62e-04 | 951 | 101 | 14 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | USP46 SESN1 SVEP1 LRIG2 FBN1 FBN2 HMCN1 LRP1 INSYN2B LTBP1 ZMYM3 ADGRA3 | 2.05e-04 | 740 | 101 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | FBLN5 ADAMTSL1 ITGA2 ABLIM3 SVEP1 SNED1 FBLN2 FBN1 HMCN1 SUSD2 LRP1 ADAMTS18 INSYN2B LTBP2 | 2.09e-04 | 975 | 101 | 14 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | FBLN5 ADAMTSL1 CTSC GRN SVEP1 FBLN2 FBN1 HMCN1 MTUS1 SUSD2 LRP1 LTBP2 | 3.23e-04 | 778 | 101 | 12 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 3.54e-04 | 127 | 101 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.83e-04 | 466 | 101 | 9 | GSM777050_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.53e-04 | 134 | 101 | 5 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.55e-04 | 288 | 101 | 7 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 4.69e-04 | 207 | 101 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_1000 | CACNA2D2 LAMA5 LAMC2 CUBN CRELD1 SCUBE2 TIA1 LPIN2 CD79B LTBP1 NOTCH1 ADGRA3 | 4.69e-04 | 811 | 101 | 12 | gudmap_developingKidney_e15.5_S-shaped body_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.32e-04 | 212 | 101 | 6 | gudmap_developingKidney_e15.5_S-shaped body_1000_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 5.33e-04 | 388 | 101 | 8 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 5.33e-04 | 388 | 101 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_PulmonMicrovasc_top-relative-expression-ranked_500 | ADAMTSL1 ITGA2 ADAMTSL3 ABLIM3 CEACAM1 MTUS1 ADAMTS18 INSYN2B NOTCH4 | 5.92e-04 | 495 | 101 | 9 | PCBC_ctl_PulmonMicrovasc_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_500 | 6.35e-04 | 82 | 101 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 6.69e-04 | 146 | 101 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 7.39e-04 | 408 | 101 | 8 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 7.93e-04 | 87 | 101 | 4 | GSM777050_100 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | FBLN5 ADAMTSL3 SVEP1 SNED1 FBLN2 FBN1 HMCN2 LRP1 LTBP1 LTBP2 | 2.02e-11 | 185 | 104 | 10 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | FBLN5 ADAMTSL3 SVEP1 SNED1 FBLN2 FBN1 HMCN2 LRP1 LTBP1 LTBP2 | 2.37e-11 | 188 | 104 | 10 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FBLN5 ADAM15 SLCO1B3 JAG2 FBLN2 FBN1 HMCN1 LTBP1 CSMD1 NOTCH4 | 2.77e-11 | 191 | 104 | 10 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FBLN5 ADAMTSL3 SVEP1 SNED1 FBLN2 FBN1 HMCN1 LRP1 LTBP1 LTBP2 | 4.36e-11 | 200 | 104 | 10 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-10 | 184 | 104 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-10 | 184 | 104 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-10 | 184 | 104 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.43e-10 | 185 | 104 | 9 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.56e-10 | 189 | 104 | 9 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.56e-10 | 189 | 104 | 9 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.87e-10 | 190 | 104 | 9 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-10 | 192 | 104 | 9 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-10 | 192 | 104 | 9 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-10 | 192 | 104 | 9 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.25e-10 | 194 | 104 | 9 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.64e-10 | 195 | 104 | 9 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.64e-10 | 195 | 104 | 9 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 8.64e-10 | 195 | 104 | 9 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.64e-10 | 195 | 104 | 9 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.08e-09 | 200 | 104 | 9 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-09 | 200 | 104 | 9 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.08e-09 | 200 | 104 | 9 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-09 | 175 | 104 | 8 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.35e-08 | 186 | 104 | 8 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.35e-08 | 186 | 104 | 8 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.35e-08 | 186 | 104 | 8 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-08 | 187 | 104 | 8 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-08 | 187 | 104 | 8 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-08 | 187 | 104 | 8 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-08 | 188 | 104 | 8 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-08 | 189 | 104 | 8 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-08 | 190 | 104 | 8 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-08 | 190 | 104 | 8 | eae5bcdb8a35f3fba4d25854c1a43f83f80832a2 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-08 | 190 | 104 | 8 | 3346bfd0474828b3729cffa9f4cc57b04dd30443 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-08 | 190 | 104 | 8 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-08 | 190 | 104 | 8 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.66e-08 | 191 | 104 | 8 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.66e-08 | 191 | 104 | 8 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.72e-08 | 192 | 104 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.72e-08 | 192 | 104 | 8 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.80e-08 | 193 | 104 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.95e-08 | 195 | 104 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-08 | 196 | 104 | 8 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-08 | 196 | 104 | 8 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.02e-08 | 196 | 104 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.19e-08 | 198 | 104 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.19e-08 | 198 | 104 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.19e-08 | 198 | 104 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.28e-08 | 199 | 104 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-08 | 199 | 104 | 8 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.28e-08 | 199 | 104 | 8 | 993fa050a095017135a6e723c77cd38b9d782e58 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-08 | 200 | 104 | 8 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-08 | 200 | 104 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-08 | 200 | 104 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-08 | 200 | 104 | 8 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-08 | 200 | 104 | 8 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.37e-08 | 200 | 104 | 8 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 2.37e-08 | 200 | 104 | 8 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.37e-08 | 200 | 104 | 8 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-08 | 200 | 104 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-08 | 200 | 104 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-08 | 200 | 104 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-08 | 200 | 104 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.37e-08 | 200 | 104 | 8 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.37e-08 | 200 | 104 | 8 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-08 | 200 | 104 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.37e-08 | 200 | 104 | 8 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-08 | 200 | 104 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-07 | 160 | 104 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-07 | 160 | 104 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-07 | 170 | 104 | 7 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-07 | 172 | 104 | 7 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-07 | 176 | 104 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-07 | 176 | 104 | 7 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-07 | 176 | 104 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-07 | 176 | 104 | 7 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.32e-07 | 181 | 104 | 7 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-07 | 182 | 104 | 7 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-07 | 184 | 104 | 7 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.59e-07 | 184 | 104 | 7 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-07 | 186 | 104 | 7 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-07 | 186 | 104 | 7 | ff6ccfdf2509f96caa10281c29a95b432f6c6dcc | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-07 | 186 | 104 | 7 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.79e-07 | 186 | 104 | 7 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-07 | 186 | 104 | 7 | a7ab70b049742dfe7ee30557031bfac6412edf52 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.89e-07 | 187 | 104 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.89e-07 | 187 | 104 | 7 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-07 | 188 | 104 | 7 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 3.00e-07 | 188 | 104 | 7 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.00e-07 | 188 | 104 | 7 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-07 | 189 | 104 | 7 | fccadf8efbef17b7f12291b069c71060a71b04e2 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-07 | 189 | 104 | 7 | 1e1afa66b32ae752c0a42b02b80f10205464569c | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-07 | 190 | 104 | 7 | 2abeb013bb83c578e67dcb985ba44ca63134950b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-07 | 190 | 104 | 7 | d13fd234caa3fc69d8a59bc0060cdacdf716ee55 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-07 | 190 | 104 | 7 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.22e-07 | 190 | 104 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.34e-07 | 191 | 104 | 7 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.34e-07 | 191 | 104 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.34e-07 | 191 | 104 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-07 | 192 | 104 | 7 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| Computational | Metal / Ca ion binding. | 1.97e-06 | 133 | 69 | 8 | MODULE_324 | |
| Computational | Adhesion molecules. | 3.15e-05 | 141 | 69 | 7 | MODULE_122 | |
| Computational | Trachea genes. | CTSC LAMA5 GRN FBLN2 FCGBP MTUS1 LRP1 CD79A LTBP1 ZMYM3 NOTCH3 | 6.02e-05 | 415 | 69 | 11 | MODULE_6 |
| Computational | DRG (dorsal root ganglia) genes. | 1.56e-04 | 384 | 69 | 10 | MODULE_2 | |
| Computational | Placenta genes. | CTSC LAMA5 GRN TNFRSF10C FBLN2 FBN2 FCGBP LRP1 LTBP1 LTBP2 NOTCH3 | 1.60e-04 | 463 | 69 | 11 | MODULE_38 |
| Drug | zoledronic acid | FCRL2 FBLN5 TNFRSF9 CTSC DNER OLFM4 LAMA5 LAMC2 CUBN ADAMTSL3 ITGB2 SESN1 PCGF5 LPIN1 FBN1 FCGBP HMCN1 LRP3 ABCG2 L3MBTL3 SYT13 NOTCH3 | 5.58e-07 | 1472 | 103 | 22 | ctd:C088658 |
| Drug | pitavastatin | 8.73e-07 | 114 | 103 | 7 | CID005282451 | |
| Drug | Rgd Peptide | 1.42e-06 | 239 | 103 | 9 | CID000104802 | |
| Drug | lead stearate | 2.26e-06 | 84 | 103 | 6 | CID000061258 | |
| Drug | monatepil | 8.60e-06 | 29 | 103 | 4 | CID000060810 | |
| Drug | pyrachlostrobin | FCRL2 FBLN5 LAMA5 GRN ADAMTSL3 ITGB2 SVEP1 FBLN2 FBN1 LTBP1 LTBP2 NOTCH1 NOTCH2 NOTCH3 | 1.73e-05 | 811 | 103 | 14 | ctd:C513428 |
| Drug | Simvastatin | 2.03e-05 | 2 | 103 | 2 | DB00641 | |
| Drug | MNPA | 2.05e-05 | 123 | 103 | 6 | CID000001301 | |
| Drug | beta-Naphthoflavone | FBLN5 CTSC LAMA5 HMGCR CEACAM1 LPIN1 FBLN2 MTUS1 LPIN2 LTBP1 LTBP2 ABCG2 CSMD1 NOTCH1 | 2.17e-05 | 828 | 103 | 14 | ctd:D019324 |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; PC3; HT_HG-U133A | 2.91e-05 | 194 | 103 | 7 | 4262_DN | |
| Drug | radicicol; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.00e-05 | 195 | 103 | 7 | 5952_UP | |
| Drug | novobiocin sodium, USP; Down 200; 100uM; PC3; HG-U133A | 3.21e-05 | 197 | 103 | 7 | 435_DN | |
| Drug | rhamnose | 3.48e-05 | 356 | 103 | 9 | CID000000840 | |
| Drug | Grgds | 3.77e-05 | 83 | 103 | 5 | CID000123811 | |
| Drug | CH2Br | 4.82e-05 | 16 | 103 | 3 | CID000140103 | |
| Drug | DMF 3 | 6.06e-05 | 3 | 103 | 2 | CID000007026 | |
| Drug | Acid Blue 45 | 6.06e-05 | 3 | 103 | 2 | CID000067196 | |
| Drug | AIS C | 6.06e-05 | 3 | 103 | 2 | CID003082878 | |
| Disease | connective tissue disease (implicated_via_orthology) | 4.01e-08 | 3 | 102 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | TNFRSF9 OBSCN SLCO1B3 CUBN ADAMTSL3 LPIN1 FBLN2 FBN2 DMKN LRP1 ADAMTS18 ABCG2 EPHA1 | 9.39e-07 | 702 | 102 | 13 | C0009402 |
| Disease | Carcinoma, Pancreatic Ductal | 1.36e-06 | 24 | 102 | 4 | C0887833 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 1.39e-06 | 7 | 102 | 3 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 1.39e-06 | 7 | 102 | 3 | DOID:3620 (implicated_via_orthology) | |
| Disease | brain cancer (implicated_via_orthology) | 1.90e-06 | 26 | 102 | 4 | DOID:1319 (implicated_via_orthology) | |
| Disease | dementia (is_implicated_in) | 8.63e-06 | 12 | 102 | 3 | DOID:1307 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 1.02e-05 | 215 | 102 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | central corneal thickness | 1.23e-05 | 309 | 102 | 8 | EFO_0005213 | |
| Disease | body surface area | CYTH1 DNER ADAMTSL3 FBLN2 UTP18 FBN1 FBN2 CD79B LTBP1 LTBP2 L3MBTL3 | 1.43e-05 | 643 | 102 | 11 | EFO_0022196 |
| Disease | vital capacity | ADAMTSL1 CACNA2D2 DNER ADAMTSL3 ABLIM3 PCGF5 SVEP1 TMEFF1 HMCN1 ADAMTS18 CD79B LTBP1 LTBP2 L3MBTL3 FBN3 | 2.25e-05 | 1236 | 102 | 15 | EFO_0004312 |
| Disease | corneal resistance factor | 2.74e-05 | 451 | 102 | 9 | EFO_0010067 | |
| Disease | myoglobinuria (implicated_via_orthology) | 3.54e-05 | 3 | 102 | 2 | DOID:0080108 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 3.54e-05 | 3 | 102 | 2 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 3.54e-05 | 3 | 102 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 3.54e-05 | 3 | 102 | 2 | C1869114 | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.01e-05 | 55 | 102 | 4 | C0079744 | |
| Disease | Malignant neoplasm of skin | 5.29e-05 | 59 | 102 | 4 | C0007114 | |
| Disease | Skin Neoplasms | 5.29e-05 | 59 | 102 | 4 | C0037286 | |
| Disease | blood nickel measurement | 6.22e-05 | 120 | 102 | 5 | EFO_0007583 | |
| Disease | aspartate aminotransferase measurement | FBLN7 CACNA2D2 OBSCN SLCO1B3 CUBN TMEFF1 LPIN1 NAA25 HMCN2 CSMD1 L3MBTL3 NOTCH4 | 6.86e-05 | 904 | 102 | 12 | EFO_0004736 |
| Disease | scoliosis (is_implicated_in) | 7.07e-05 | 4 | 102 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome | 7.07e-05 | 4 | 102 | 2 | cv:C0265313 | |
| Disease | Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement | 7.07e-05 | 4 | 102 | 2 | EFO_0803113 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 7.07e-05 | 4 | 102 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | cutis laxa (is_implicated_in) | 7.07e-05 | 4 | 102 | 2 | DOID:3144 (is_implicated_in) | |
| Disease | FEV/FEC ratio | DNER LAMC2 ADAMTSL3 TG CRELD1 FBN1 FCGBP HMCN1 MTUS1 LRP1 LTBP1 LTBP2 CSMD1 L3MBTL3 | 8.46e-05 | 1228 | 102 | 14 | EFO_0004713 |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 1.10e-04 | 27 | 102 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 1.18e-04 | 5 | 102 | 2 | DOID:2741 (implicated_via_orthology) | |
| Disease | intermediate coronary syndrome (is_implicated_in) | 1.18e-04 | 5 | 102 | 2 | DOID:8805 (is_implicated_in) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (is_implicated_in) | 1.18e-04 | 5 | 102 | 2 | DOID:0110274 (is_implicated_in) | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.52e-04 | 30 | 102 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | Glioblastoma | 1.66e-04 | 79 | 102 | 4 | C0017636 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.74e-04 | 80 | 102 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | Clear cell sarcoma of kidney | 1.76e-04 | 6 | 102 | 2 | C0334488 | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.85e-04 | 32 | 102 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | alcoholic liver disease | 1.91e-04 | 82 | 102 | 4 | EFO_0008573 | |
| Disease | Giant Cell Glioblastoma | 2.10e-04 | 84 | 102 | 4 | C0334588 | |
| Disease | cortical surface area measurement | ADAMTSL1 ZAN ADAM15 HMGCR ADAMTSL3 SVEP1 TG JAG2 FBN1 FBN2 ADAMTS18 ADAMTS20 L3MBTL3 FBN3 | 2.18e-04 | 1345 | 102 | 14 | EFO_0010736 |
| Disease | diffuse plaque measurement | ADAMTSL1 ABLIM3 LRP1B EYS FBLN2 FBN2 ADAMTS18 FBN3 ADGRA3 NOTCH4 | 3.00e-04 | 758 | 102 | 10 | EFO_0010699 |
| Disease | albuminuria | 3.23e-04 | 94 | 102 | 4 | EFO_0004285 | |
| Disease | Agammaglobulinemia, non-Bruton type | 3.27e-04 | 8 | 102 | 2 | C1832241 | |
| Disease | body weight | CYTH1 ADAMTSL3 LRP1B CRB1 CRELD1 EYS NAA25 UTP18 FBN2 CD79B LTBP1 LTBP2 L3MBTL3 | 4.08e-04 | 1261 | 102 | 13 | EFO_0004338 |
| Disease | hemangiopericytoma (is_marker_for) | 4.19e-04 | 9 | 102 | 2 | DOID:264 (is_marker_for) | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 4.19e-04 | 9 | 102 | 2 | EFO_0800562 | |
| Disease | Mammary Carcinoma, Human | 4.84e-04 | 525 | 102 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.84e-04 | 525 | 102 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 4.96e-04 | 527 | 102 | 8 | C1458155 | |
| Disease | aortic aneurysm | 5.23e-04 | 10 | 102 | 2 | EFO_0001666 | |
| Disease | allergic rhinitis (biomarker_via_orthology) | 5.23e-04 | 10 | 102 | 2 | DOID:4481 (biomarker_via_orthology) | |
| Disease | body composition measurement | 5.67e-04 | 193 | 102 | 5 | EFO_0005106 | |
| Disease | Breast Carcinoma | 5.68e-04 | 538 | 102 | 8 | C0678222 | |
| Disease | eosinophil count | CTSC TNFRSF10C SESN1 SVEP1 TG NAA25 PRG3 LTBP2 IL17RA MUC5AC NOTCH1 NOTCH2 NOTCH4 IL9 | 6.01e-04 | 1488 | 102 | 14 | EFO_0004842 |
| Disease | Glioblastoma Multiforme | 6.07e-04 | 111 | 102 | 4 | C1621958 | |
| Disease | Marfan Syndrome | 6.38e-04 | 11 | 102 | 2 | C0024796 | |
| Disease | Agammaglobulinemia | 7.64e-04 | 12 | 102 | 2 | C0001768 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 8.29e-04 | 53 | 102 | 3 | C4707243 | |
| Disease | Migraine Disorders | 9.00e-04 | 13 | 102 | 2 | C0149931 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 9.00e-04 | 13 | 102 | 2 | EFO_0800474 | |
| Disease | renal sinus adipose tissue measurement | 9.00e-04 | 13 | 102 | 2 | EFO_0004864 | |
| Disease | Squamous cell carcinoma | 9.19e-04 | 124 | 102 | 4 | C0007137 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 9.37e-04 | 447 | 102 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | eosinophil percentage of leukocytes | 1.14e-03 | 746 | 102 | 9 | EFO_0007991 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.21e-03 | 15 | 102 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.21e-03 | 15 | 102 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.21e-03 | 15 | 102 | 2 | C0154091 | |
| Disease | response to statin, LDL cholesterol change measurement | 1.21e-03 | 15 | 102 | 2 | EFO_0007804, GO_0036273 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 1.21e-03 | 15 | 102 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | OBSCN CUBN JAG2 NAA25 PER3 ABCG2 L3MBTL3 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.23e-03 | 1074 | 102 | 11 | C0006142 |
| Disease | serum gamma-glutamyl transferase measurement | ADAM15 CYTH1 SLCO1B3 ITGB2 SLCO1B7 EYS CSMD1 L3MBTL3 NOTCH2 EPHA1 | 1.26e-03 | 914 | 102 | 10 | EFO_0004532 |
| Disease | ceramide measurement | 1.37e-03 | 235 | 102 | 5 | EFO_0010222 | |
| Disease | Dementia | 1.56e-03 | 17 | 102 | 2 | C0497327 | |
| Disease | X-21441 measurement | 1.56e-03 | 17 | 102 | 2 | EFO_0800814 | |
| Disease | Hypogammaglobulinemia | 1.56e-03 | 17 | 102 | 2 | C0086438 | |
| Disease | interstitial lung disease | 1.64e-03 | 67 | 102 | 3 | EFO_0004244 | |
| Disease | forced expiratory volume | ADAMTSL1 ADAMTSL3 ABLIM3 PCGF5 SVEP1 EYS SCUBE2 CD79B L3MBTL3 | 1.67e-03 | 789 | 102 | 9 | EFO_0004314 |
| Disease | fatty acid measurement, linoleic acid measurement | 1.71e-03 | 68 | 102 | 3 | EFO_0005110, EFO_0006807 | |
| Disease | Age-related macular degeneration | 1.75e-03 | 18 | 102 | 2 | cv:C0242383 | |
| Disease | Carcinoma of bladder | 1.75e-03 | 18 | 102 | 2 | C0699885 | |
| Disease | systemic lupus erythematosus | 1.82e-03 | 799 | 102 | 9 | MONDO_0007915 | |
| Disease | aortic measurement | 1.82e-03 | 251 | 102 | 5 | EFO_0020865 | |
| Disease | pentachlorophenol measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0022056 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CDCYVQGSVANRTGS | 191 | Q7L8C5 | |
| YSVRCSQCQGTAQDG | 366 | P21709 | |
| GSSNVIQCYRCGDTC | 16 | O94929 | |
| RCDAPCGYNVTSQNG | 2141 | Q96PZ7 | |
| NASYNAIIDCGNCSR | 1026 | Q9NY47 | |
| CLQTANTRGNAFGSC | 546 | Q13444 | |
| CCPGRSSYSVQVNVQ | 1061 | Q8IWK6 | |
| GTAYCYNGQCQTTDN | 486 | Q9Y3Q7 | |
| QGYTCVAEGQCQRGS | 406 | P28799 | |
| NATGNNPCNYATCTG | 596 | Q9UNQ0 | |
| CRVQEGNESYQQSCG | 106 | P11912 | |
| TNGVCVNTDGSFRCE | 2096 | Q75N90 | |
| CNNTSEVYQGCGTEL | 126 | P40259 | |
| VQSECSVSCGGGYIN | 881 | Q8TE60 | |
| SVTCGSGVQQRDVYC | 1486 | P59510 | |
| DSSQCANNCGFSYRQ | 1596 | P59510 | |
| ECLSGGNYCSQNCAR | 131 | Q96JM7 | |
| QNGGTCVEGVNQYRC | 146 | Q53RD9 | |
| NGGVCVDGVNTYNCR | 271 | Q04721 | |
| CQNGGTCDNLVNGYR | 766 | Q04721 | |
| NNINECTESSCFNGG | 986 | Q04721 | |
| TEGANCGADQFCVNT | 251 | Q96HD1 | |
| FEQSLSCQAQGGCSR | 756 | Q96F46 | |
| NCSASQVCSQDGPLY | 226 | Q86SE9 | |
| YCQSSTNFVDCSQQG | 26 | Q9HBL6 | |
| NTLGSFECQCLQGYT | 431 | P46531 | |
| DFCQNGGTCIVTAGN | 4291 | Q9NZR2 | |
| GYNTCRNGGECTVNG | 2901 | Q5T1H1 | |
| NSGNASRCVSGCMYQ | 16 | Q5T3J3 | |
| FENGSCSGDCSNYIQ | 146 | Q4G1C9 | |
| GNQCACSSGKVTSEY | 261 | Q9ULD2 | |
| YIACGQDAAQNVGSS | 761 | P04035 | |
| GQAQLAQEGTYTCEC | 2231 | Q8NDA2 | |
| AQEGTYTCECSNVVG | 2236 | Q8NDA2 | |
| YTCECSNVVGNSSQD | 2241 | Q8NDA2 | |
| SREFQCDAYTCSNGG | 711 | Q9Y219 | |
| PTCYCNSSFQLQADG | 131 | Q07954 | |
| TLCTATCGNYGFQSR | 1676 | Q8N6G6 | |
| SCINTVGSYTCQRNP | 826 | P98095 | |
| RNTCPQTEYCVTGNN | 946 | P56645 | |
| NVCANGDCSNLEGSY | 1046 | Q14766 | |
| NTEGSFRCTCGQGYQ | 1096 | Q14766 | |
| RNTEGSFQCVCDQGY | 1136 | Q14766 | |
| SCIDGQCVNTEGSYN | 1476 | Q14766 | |
| LNGGTCVDGVNTYNC | 246 | Q9UM47 | |
| RYCQCNNGVFQSTDT | 171 | Q15438 | |
| VTTQYQGTCRCEGTI | 651 | Q14693 | |
| GSGLCYTPADRCNNQ | 426 | O75074 | |
| GNSCTNQDGYRELVT | 141 | Q96FV0 | |
| SYRAGQTIRVGCNTC | 871 | P98088 | |
| QTIRGQYCDICTAAN | 96 | O15230 | |
| CTYRPSAQQSGDNCL | 1031 | O15230 | |
| GTCNTECLYRQTFQA | 206 | Q9H579 | |
| RTTPRCYVCDQQTNG | 291 | O15541 | |
| YFSCEQPCNQTTAGN | 106 | P15248 | |
| AQQCGNQYYTTGVCS | 136 | P17301 | |
| GEYTCVASNVAGTNN | 956 | Q96RW7 | |
| NSRILCSVYCNGSQI | 91 | P32942 | |
| CSVYCNGSQITGSSN | 96 | P32942 | |
| VYTCLAQNTGGQVLC | 6426 | Q5VST9 | |
| FAEAQNVCSRCYGGN | 121 | Q9Y2Y8 | |
| YIGKNCECQTQGRSS | 476 | P05107 | |
| TLVQCFNTQGSFYCG | 276 | O60494 | |
| GYGSVRASNQNEGCT | 216 | Q6E0U4 | |
| SYTCHANNSVTGCNR | 296 | P13688 | |
| DFQGTCNYVLATTGC | 2891 | Q9Y6R7 | |
| NNQGSYTCQCRAGYQ | 506 | P35555 | |
| GNGTCRNTIGSFNCR | 1901 | P35555 | |
| QVAGGRVSQYTCCAA | 446 | Q8IX06 | |
| QEVVSCSQYAQGCEG | 286 | P53634 | |
| VHQYGDLTNNCNSCG | 131 | O14618 | |
| NSTGVQDCYRGDGQS | 1381 | P08519 | |
| LGRCYLNTVNGQCAN | 551 | Q14767 | |
| CGPQFQSRATCNNYT | 191 | Q5T749 | |
| QTGNGFRCLNCNDNT | 46 | Q13753 | |
| TQICINTEGGYTCSC | 141 | Q9UBX5 | |
| YSCEANNGLGAQCSE | 366 | Q96LA5 | |
| INAQCVNTPGSYRCA | 1421 | P35556 | |
| ICSNGQCINTDGSFR | 2181 | P35556 | |
| NEKTNLTCYNGGNCT | 1261 | P82279 | |
| LTCYNGGNCTEFQTE | 1266 | P82279 | |
| SSPCQNNGTCYVDGV | 436 | Q8NFT8 | |
| NGGCQQVCVNTVGSY | 411 | Q9NQ36 | |
| YSCCSQKRSGERQSN | 266 | Q8N697 | |
| SYCGNCQTAVVSAQP | 106 | A6NNL0 | |
| SYCGNCQTAVVSAQP | 106 | B1AL46 | |
| NTCYCLSVRAANTAG | 251 | Q8TC99 | |
| QYNFSLVACTNGGCT | 4416 | O75445 | |
| ACGSNCGVVNIYNQD | 441 | Q9Y5J1 | |
| GSGQQCCYTADGTQL | 361 | Q9UGT4 | |
| SSDSSQYVQCVAGCL | 191 | Q9UI12 | |
| PSVSNYCICDITNGN | 236 | Q9Y6P5 | |
| QENSTQCTDCGGGQS | 3521 | A2VEC9 | |
| STNSCGARGACRIYN | 556 | G3V0H7 | |
| YTGQRCEENINECSS | 1261 | Q4LDE5 | |
| QNGGTCQDGLDTYTC | 286 | Q99466 | |
| SNFTGSVDDRGTCQC | 71 | Q6UX06 | |
| VENGSAVCVCQAGYT | 366 | Q8TER0 | |
| GSQFGCCYDNVATAA | 721 | O95428 | |
| QEYGEVTCCLGSSAN | 991 | Q12767 | |
| SCGAQGACRIYNSVF | 606 | Q9NPD5 | |
| NSFSSAGGQRTCDIC | 51 | Q07011 | |
| CNPCTEGVDYTNASN | 66 | O14798 | |
| GLVNFGNTCYCNSVL | 36 | P62068 | |
| CGSNGDTYQNECFLR | 111 | Q8IYR6 | |
| STLVQNSCCSYVVNG | 196 | Q9H0M0 | |
| NSCCSYVVNGDNTPS | 201 | Q9H0M0 | |
| GSFQTVQCQNDGRSC | 56 | P01266 | |
| VNQSSPSNCTVYCGG | 206 | P31483 | |
| YCSQTCQRGVTEQLD | 681 | Q14202 | |
| CQALQAFGATCQSQG | 2181 | Q9Y493 | |
| SQTGQCQSFVYGGCE | 406 | Q8TEU8 | |
| CTVTCGGGYQLNSAE | 351 | P82987 | |
| NFYRTGQDLNNCSTC | 451 | A6NMK8 | |
| YVANSSNCISGVCSV | 476 | Q3SY84 | |
| SITTQYQGTCRCAGT | 661 | Q92539 | |
| TGTRVICSDCYDNAN | 896 | O94898 | |
| NSGCSQCQISSFYLV | 766 | Q14CX7 |